NEW YORK (GenomeWeb) – Genomic informatics firm Cartagenia today announced a partnership to integrate MedGenome's OncoMD Cancer database of clinically actionable cancer variants into its Bench NGS software platform.

MedGenome's OncoMD is a cancer analytics platform that includes proprietary, curated data on 1.7 million cancer mutations, containing relevant functional information, data on drug sensitivity, and lists of potential clinical trials for patient enrollment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.